The focal adhesion kinase (FAK) and the related protein-tyrosine kinase 2-beta (Pyk2) are highly versatile multidomain scaffolds central to cell adhesion, migration, and survival. Due to their key role in cancer metastasis, understanding and inhibiting their functions are important for the development of targeted therapy. Because FAK and Pyk2 are involved in many different cellular functions, designing drugs with partial and function-specific inhibitory effects would be desirable. Here, we summarise recent progress in understanding the structural mechanism of how the tug-of-war between intramolecular and intermolecular interactions allows these protein 'nanomachines' to become activated in a site-specific manner.
minimise where possible. We also briefly discuss how this mechanistic framework helps us to understand kinase-independent FAK functions in other environments and how it may support calciumsensing by Pyk2.
Multiple cellular functions of FAK
FAK is essential in embryonic development and wound healing (see (Arold, 2011; Hall et al., 2011; Schaller, 2010) ). In adult tissue, FAK is expressed only at low levels. However, FAK is overexpressed in most cancers, and it endows cancer cells with functions that normal adult tissue cells do not have, such as the capacity to survive following detachment from the supporting structure. In so doing, FAK becomes a key player in cancer cell metastasis and tissue invasion (Fu et al., 2012; Sulzmaier et al., 2014; Zhang and Hochwald, 2014) .
As indicated by its name, FAK is a central player for the assembly and disassembly of FAs (Arold, 2011; Hall et al., 2011; Mitra et al., 2005; Schaller, 2010) . FAs are large and dynamic macromolecular assemblies through which the actin cytoskeleton is connected to the extracellular matrix (ECM). In addition to anchoring the cell, FAs encode the state of the ECM into intracellular biochemical pathways that control cell morphology, migration, differentiation, proliferation, and survival (Gumbiner, 1996; Ridley et al., 2003; Wehrle-Haller and Imhof, 2002) . FAK is recruited to FAs in response to integrin-mediated cell adhesion. However, FAK is also involved in signalling of other cell surface receptors (including G protein-coupled receptors, the T cell receptor, the deleted-in-coloncancer netrin receptor and transmembrane tyrosine kinases) and is acting in many cellular environments, such as lamellipodia, microtubules and the nucleus (Chapman and Houtman, 2014; Schaller, 2010; Zhao and Guan, 2009) . FAK can promote different effects in the same subcellular localisation (such as assembly and disassembly of FAs); it can also produce convergent effects at different subcellular localisations (such as cancer cell invasion and metastasis in lamellipodia or the nucleus) (Arold, 2011; Cance and Golubovskaya, 2008; Hall et al., 2011; Schaller, 2010) . This functional versatility raises the question of how FAK achieves sitespecific and cell stateespecific functions.
FAK consists of a central kinase domain, flanked by two noncatalytic domains, the band 4.1, ezrin, radixin, moesin (FERM) domain and the focal adhesion targeting (FAT) domain. These domains are separated by long linkers of about 50 (FERM-kinase) and 220 (kinase-FAT) residues (Fig. 1 ). More than 50 ligands have been reported for FAK, and each domain and linker region has its own set of ligands. Some ligands bind to FAK in the nucleus, and others in the cytoplasm ( Fig. 1 ; red and black, respectively). A subset of cytoplasmic ligands (green) is incompatible with or counteracts autophosphorylation of FAK tyrosine 397.
The major role of the FAK kinase domain appears to be the autophosphorylation of FAK Y397 (Ciccimaro et al., 2006) . Y397 is situated in the FERM-kinase linker, adjacent to a proline-rich motif (PR1), and autophosphorylation of Y397 has to proceed in trans in the full-length standard form of FAK (Brami-Cherrier et al., 2014; Toutant et al., 2002) . Once phosphorylated, this region constitutes a bi-dentate binding site for the Src-homology 2 (SH2) and SH3 domains of Src family kinases Fyn and Src (which bind to pY397 and PR1, respectively) (Arold et al., 2001; Schaller et al., 1994; Thomas et al., 1998) (Fig. 1 ). The interaction with FAK activates these Srcfamily kinases, which then provide most kinase activity associated with FAK, including phosphorylation of tyrosines within FAK (including Y576/Y577 in the kinase activation loop, Y861 in the kinase-FAT linker, and Y925 in the FAT domain) (Schaller et al., 1999 (Schaller et al., , 1994 Schlaepfer et al., 1994; Xie et al., 2008) . Thus, autophosphorylation of Y397 triggers the kinase-dependent functions of the Src:FAK complex. In the absence of Y397 autophosphorylation, FAK binds to different ligands and performs different functions (Corsi et al., 2009) . Hence FAK can be seen as a scaffolding protein with a Y397-phosphorylation switch between different conformational and functional states (Fig. 1) .
New insights into the structure and regulation of individual FAK domains
The atomic-resolution 3D structures of the individual domains of FAK have been previously described [ (Fig. 2) ; for a detailed review, see (Alam et al., 2014; Arold, 2011; Hall et al., 2011) ]. The FAK FERM domain is composed of three lobes (F1eF3) and is structurally similar to the FERM domains of those proteins after which it was named (band 4.1, ezrin, radixin and moesin) (Ceccarelli et al., 2006; Girault et al., 1999) . However, the FAK FERM domain has adapted this scaffold to engage different interactions (such as binding to transmembrane receptor tails, or intramolecular interactions), or to engage in the same type of interactions differently (for example binding to phospholipid head groups) (Arold, 2011; Ceccarelli et al., 2006; Hall et al., 2011) . The crystal structure of a FAK fragment comprising the FERM and kinase domains (residues 31-686) revealed that the FERM domain can dock onto the kinase domain ( Fig. 2) (Lietha et al., 2007) . This assembled FERM-kinase conformation is stabilised by binding of ATP to the kinase domain, yet is incompatible with phosphorylation of Y576/Y577 in the kinase activation loop (Goni et al., 2014; Lietha et al., 2007; Zhou et al., 2015) . The FAK kinase domain cannot efficiently autophosphorylate its activation loop tyrosines Y576/Y577, but requires Src kinases for this modification (Ciccimaro et al., 2006) . Binding of the Src kinase SH2 domain to pY397 requires dissociation of the contacts between pY397 and the FERM F1 lobe ( Fig. 2A and data not shown), suggesting that this event weakens the FERM:kinase interaction. Hence Y397 autophosphorylation, which leads to phosphorylation of Y576/Y577 by Src kinases, ultimately promotes an open, disassembled FAK conformation, as experimentally observed using FRET sensors (Cai et al., 2008; Goni et al., 2014; Lietha et al., 2007) . Thus, the presence of ATP (which is expected to be constitutive, given the high ATP concentrations in the cell) and phosphorylation of the kinase activation loop stabilise structurally and functionally distinct structural states.
Despite forming a simple 4-helix bundle structure, the~140 residue FAT domain also possesses several layers of regulation, linked to conformational plasticity ( Fig. 2B) (Alam et al., 2014; Arold et al., 2002; Dixon et al., 2004; Hayashi et al., 2002; Kadare et al., 2015; Prutzman et al., 2004) . The interaction between FAT and paxillin LD motifs results in FAK being recruited to FAs (Fig. 2C ) (Brown et al., 1996) . FAT binds two helical LD motifs, one between helices H1 and H4 (site 1/4), the other one between helices H2 and H3 (site 2/3) (Bertolucci et al., 2005; Gao et al., 2004; Hoellerer et al., 2003) , whereas FAT-homology domains (FAHs) of other FAlocalising proteins (CCM3, GIT1/2 and vinculin) bind only one LD motif (Alam et al., 2014; Brown et al., 1996; Li et al., 2011; Schmalzigaug et al., 2007; Turner et al., 1990; Zhang et al., 2008) . FAT binds also two CD4 endocytosis motifs, in a structurally similar way to LD motifs, allowing CD4 to recruit FAK for T cell receptor signalling (Garron et al., 2008) . Conversely, the FAT helix 4 is sufficient to bind to the talin FERM F3 lobe, and the FAT 4-helix bundle structure is not required for this interaction (Hayashi et al., 2002; Lawson et al., 2012) .
Phosphorylation and subsequent interaction of Y925 [located on helix 1 (H1) of FAT] with the Grb2 SH2 domain requires opening of H1 (Arold et al., 2002; Schlaepfer et al., 1994) . H1-opening is promoted by the P 944 XPP motif between H1 and H2 ( Fig. 2B and D , 2015) . Despite being only a low-probability event in vitro (Arold et al., 2002; Zhou et al., 2006) , H1-opening is required in cells for a subset of FAK functions, including phosphorylation of Y925 and FA turnover (Kadare et al., 2015) . However, H1-opening is incompatible with FAT binding to paxillin LD motifs (Kadare et al., 2015) . In crystal structures of apo-FAT, the S 910 PPP motif, situated in an N-terminal extension of FAT, binds to site 1/4 (Arold et al., 2002; Kadare et al., 2015) (Fig. 2B ). This interaction is incompatible with both FAT H1 opening and binding of LD motifs to site 1/4 (Hoellerer et al., 2003; Kadare et al., 2015) . The S 910 PPP motif, when (Alam et al., 2014; Arold, 2011; Bongiorno-Borbone et al., 2005; Chen et al., 2001; Fujita et al., 1998; Garces et al., 2006; Hall et al., 2011; Ho et al., 2012; Nagano et al., 2010; Oh et al., 2009; Plaza-Menacho et al., 2011; Tanaka et al., 2010; Wang et al., 2014 (Zheng et al., , 2011 . The structural and mechanistic effects of S910 phosphorylation and cis/trans isomerisation remain unknown. However, given the proximity of S910 to K1032 (located on FAT H4), we speculate that phosphorylation reinforces the interaction of the pS 910 PPP motif with the FAT domain core (Fig. 2B ). Possible outcomes of S910 phosphorylation might include, but not be limited to, competition with the LD motif bound to FAT helices 1/4, or stabilisation of the 4-helix bundle structure of FAT. Recent structural insights now provide a framework to understand how different regulatory mechanisms combine to allow sitespecific conformations and functions.
Structural insight into full-length FAK
Since full-length FAK does not form crystals suitable for X-ray analysis, we have used SAXS to obtain structural insights (BramiCherrier et al., 2014) . The ab initio low-resolution shape that we obtained suggested that FAK forms dimers under our experimental conditions. Fitting of this shape by the known atomic-resolution fragments was enabled by our observation that all crystal structures that contained the FERM domain [including human (BramiCherrier et al., 2014) and avian FERM (Ceccarelli et al., 2006) and avian FERM-kinase fragments (Lietha et al., 2007) ] contained the same FERM:FERM dimer in the crystal lattice. These dimeric FERMkinase structures fitted the full-length SAXS ab initio shape very well and were used in conjunction with SAXS data on full-length FAK to investigate the position of the missing residues located Cterminal to the kinase domain. Although the low resolution precluded a precise positioning of the FAT domain, SAXS data supported that FAT attached to the F2 lobe of the FERM domain (BramiCherrier et al., 2014).
Functional implications of FAK dimerisation through the FERM domain
This full-length model suggested that FAK can be dimeric (Fig. 3A) , and that this dimer conformation requires a FERM:FERM interaction, centred on an interface formed by W266 (BramiCherrier et al., 2014) . FAK dimerisation was not anticipated, since none of the FAK fragments (FERM, kinase, FERM-kinase or FAT) formed stable dimers in solution (with the exception of the armexchanged FAT dimers, which occur in vitro under high FAT concentrations, and are unlikely to play a major role in cells) (Arold et al., 2002; Kadare et al., 2015; Lietha et al., 2007) . However, FAK self-association is apparent in vitro and in cells and requires intact W266 (Brami-Cherrier et al., 2014) . Moreover FAK transient dimerisation is needed for autophosphorylation of Y397 in vitro and in cells (Brami-Cherrier et al., 2014; Toutant et al., 2002) . In this regard, full-length FAK behaves differently from the FERM-kinase fragment, which can autophosphorylate Y397 in cis (Lietha et al., 2007) . Given the length of the FERM-kinase linker, and position of Y397 within this linker, transient dissociation of the FERM:kinase interaction is required for phosphorylation of Y397 in trans across the W266-mediated dimer. The apparent in vitro dimerisation dissociation constant (K d ) for the isolated FERM domain is onlỹ 30 mM, which explains why this interaction has gone unnoticed in previous experiments and why it is only apparent in the highly concentrated FERM domains within crystal structures (BramiCherrier et al., 2014) . From our data we estimated the apparent dimerisation K d of full-length FAK to be 150 nM, whereas the FAK concentration in cells is only about 10 nM (Brami-Cherrier et al., 2014) . These findings suggested that trans-autophosphorylation of FAK Y397, and hence activation of kinase-dependent functions, requires local enrichment and clustering of FAK. Indeed, using acceptor photobleaching and confocal microscopy, we showed that FAK self-associates and autophosphorylates specifically at FAs, suggesting that FAK reaches the required local concentration specifically and exclusively at these structures. Moreover, our data also suggested that the weak FERM:FERM dimer needs to be stabilised by additional interactions from the region that is C-terminal to the kinase domain (Brami-Cherrier et al., 2014).
FERM and FAT synergise to stabilise FAK dimerisation
The full-length structural data also suggested that the FERM domain binds to the FAT domain. We confirmed this interaction experimentally, establishing a K d of 600 nM for recombinant FAT and FERM domains. The observation that the presence of a 10-fold excess of free FAT reduced substantially the amount of dimeric FAK suggested that the FERM:FAT interaction stabilises FAK dimers by occurring in trans (Brami-Cherrier et al., 2014) , which is compatible with the length of the kinase-FAT linker. Counterintuitively, the presence of paxillin LD4 peptides enhances the association between FAT and FERM. Deletion of the N-terminal extension of FAT Fig. 3 . Similarities in the molecular architecture of FAK and Pyk2 homodimeric structures. (A) The model of dimeric full length FAK was established by combining SAXS and X-ray crystallography (Brami-Cherrier et al., 2014) . The dimeric FERM-kinase fragment was taken from the crystal lattice of PDB 2J0J. The residues outside of this fragment, including the FAT domains, were placed using SAXS (ab inito SAXS model is shown as grey surface) (Brami-Cherrier et al., 2014) . Note that the low resolution of SAXS precludes a precise positioning of FAT and linker residues (not shown). W266 (blue) is required for dimer formation in vitro and in cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66   67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130 (residues 895 to 915) decreased the binding of FAT to FERM, but the presence of LD4 peptides restored the interaction of the N-terminally deleted FAT (Brami-Cherrier et al., 2014) . The exact region of FAT that binds to FERM is unknown, as is the mechanism by which LD4 increases this interaction.
The multifunctional basic motif of the FERM domain
The binding of FERM to FAT requires the K 216 AKTRLK basic motif located in the FERM F2 lobe (Fig. 3A) , but the exact site of interaction remains to be determined (Brami-Cherrier et al., 2014) . Biosensor studies in live cells and cell-free assays have shown that the same basic motif is required for binding of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and that this interaction correlates with disassembly of the inhibitory FERM:kinase interactions and triggers autophosphorylation of Tyr397 (Cai et al., 2008; Papusheva et al., 2009) . Although the exact mode of PI(4,5)P2 binding is unknown, all-atom molecular dynamics simulations suggested an allosteric link between binding of PI(4,5)P2 to FERM F2 and the FERM F1 lobe (Zhou et al., 2015) . Work by Goni et al. shows that both the charged head group and the fatty acid chain of PI(4,5)P2 are needed to induce clustering and partial structural opening of the inhibitory FERM:kinase association, which then stimulates Y397 autophosphorylation (Goni et al., 2014) . Based on computational simulations, fluorescence measurements and crystallographic analysis of the FERM K 216 AKTRLK->AAATALK mutant, the authors proposed a model in which PI(4,5)P2 binding renders the FERM F2 lobe, and hence the association of the F2 lobe with the Cterminal lobe of the kinase domain, more flexible (Goni et al., 2014) . Rather than increasing the propensity of the kinase domain to dissociate from FERM to trans-autophoshorylate Y397 (as required within the W266-mediated FAK dimer), the authors suggested that this increased flexibility leads to dissociation of the link between the FERM F1 lobe and the N-terminal kinase lobe, while maintaining the connection between the kinase and the F2 lobe. To explain how a FERM-bound kinase can nonetheless phosphorylate Y397 in trans, the authors proposed that within PI(4,5)P2-induced clusters, FAK molecules arrange themselves to allow their kinase domains to phosphorylate Y397 of the FERM-kinase linker from their neighbouring FAK molecule. Because we found that W266-mediated FERM:FERM dimers are required for Y397 autophosphorylation in cells and in cell-free assays in the absence of PI(4,5) P2 (Brami-Cherrier et al., 2014) , the lateral Y397 transphosphorylation without FERM:kinase dissociation proposed by Goñi et al. might be an alternative and possibly synergistic route in clustered FAK populations. In both models, the FERM:kinase interaction is weakened by Src binding to pY397, and disrupted by subsequent Src phosphorylation of the FAK kinase activation loop tyrosines Y576/Y577.
Indeed, K 216 AKTRLK-dependent binding of FAK appears to be a more general mechanism of ligand-induced coactivation. This mode of action has been reported for two receptor tyrosine kinases that can activate FAK, namely the phosphorylated hepatocyte growth factor receptor (pc-Met) (Chen and Chen, 2006; Chen et al., 2011) and rearranged during transfection (RET) (Plaza-Menacho et al., 2011) . It is possible that the doubly phosphorylated pc-Met promotes FAK autophosphorylation using a charge-based mechanism reminiscent of the one used by doubly phosphorylated lipid head groups (Goni et al., 2014) . The mechanism used by RET appears to be different, because the RET:FERM interaction (which leads to phosphorylation of FAK Y576/577 by RET) is disrupted by FAK-mediated RET phosphorylation, rather than promoted through phosphorylation as observed for c-Met and lipid head groups (Plaza-Menacho et al., 2011) . How all these, and perhaps other, coactivators compete or synergise with each other and with the FERM-bound FAT domain is currently unclear and awaits further structural and functional analysis. Intriguingly, in addition to enabling activation of FAK kinasedependent functions at the plasma membrane, this basic K 216 AKTRLK motif is also part of a nuclear localisation signal (NLS), and mutation of K216 and K218 into alanine blocked nuclear accumulation . Consequently, the interaction of FAT with the FERM K 216 AKTRLK motif is expected to have an important role in localisation and activation of FAK.
pH dependent activation
The FERM domain also harbours another trigger for autoactivation. In a recent study, Ritt et al. presented direct evidence linking FAK activation to changes in physiological pH in living cells (Ritt et al., 2013) . Cancer cells are known to have a higher intracellular pH than normal cells, which is linked to cell migration and cell proliferation, all of which are processes affected by FAK activation. Decreasing intracellular pH enhances the FERM-kinase interaction and hence results in decreases in both Y397 phosphorylation and kinase activity as evident from FRET sensorebased assays (Ritt et al., 2013) . As a result, in normal cells at slightly acidic pH FAK is in an autoinhibited state whereas in alkaline cancerous cells, FAK activity and phosphorylation of Tyr397 increase leading to cell proliferation and metastasis. The ability of FAK to respond to changes in pH provides an additional mechanism of control of FAK activity in normal versus cancerous cells. Ritt et al. proposed that the mechanism behind the pH sensing ability of FAK relies on protonation of H58 on the FERM's F1 lobe ( Fig. 2A) (Ritt et al., 2013) . Protonated H58 likely forms a network of electrostatic interactions with E466 on the kinase domain and therefore enhances the autoinhibited conformation of FAK. In an independent study, based on evidence from molecular dynamic studies, Choi et al. proposed that deprotonation of His58 at higher pH, although not through direct interaction, causes conformational changes in the linker region that expose the Y397 phosphorylation site .
Conversely, a slightly acidic pH appears to increase phosphorylation of the FAT domain. Using a combination of biochemical and NMR structural analysis, Cable et al. showed that phosphorylation of Y925 and Y1007 by Src is enhanced at pH 6e6.5, as compared with pH 7.5. This effect might be linked to pH affecting the local dynamics of the FAT structure. How an increase of Src-dependent FAT phosphorylation under acidic pH conditions combines with the opposing effect of decreased Y397 autophosphorylation and Src recruitment to allow pH-dependent functions remains to be determined (Cable et al., 2012) .
Site-specific functions of FAK
Collectively, these data provide mechanistic explanations for how intramolecular and intermolecular interactions determine the site-specific functions of FAK. In the following we briefly outline how this framework may explain FAK's different actions in different subcellular environments. Sections 9.1e9.3 are illustrated in Fig. 4. 
FAK in the cytoplasm
In the cytoplasm, without mechanisms for local enrichment, the FAK concentration is too low for stable FAK dimerisation/clustering, and FAK is expected to remain monomeric (Brami-Cherrier et al., 2014) . The FERM:FAT interaction in cis, although probably less stable than in trans, may conceal the NLS on FERM and thus counteract nuclear accumulation (Brami-Cherrier et al., 2014; Lim et al., 2008; Ossovskaya et al., 2008) . Because monomeric fulllength FAK cannot autophosphorylate Y397 in cis (Brami -Cherrier 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 et al., 2014), activation of kinase-dependent functions is inhibited in the cytoplasm. Binding of the FAK familyeinteracting protein of 200 kDa (FIP200) to the FERM and kinase domains of FAK further inhibits residual kinase activity (Abbi et al., 2002) . The exact binding sites and mechanism for the inhibitory action of FIP200 are unknown.
FAK at FAs
Clustering of integrins at sites of FAs induces clustering of paxillin in the intracellular membrane-proximal space. Clustered paxillin recruits FAK through the interaction between the LD motifs and the FAT domain [other, paxillin-independent ways to recruit FAK also exist (Cooley et al., 2000) ]. This recruitment induces FAK dimers in two ways: firstly, it locally enriches FAK, bringing the local FAK concentration closer to the dimerisation K d . Secondly, paxillin binding to FAT reinforces the FERM:FAT interaction that stabilises the dimers (Brami-Cherrier et al., 2014) . FAK enrichment at FAs by paxillin likely synergises with FAK enrichment through PI(4,5)P2, which is locally synthesised at FAs (Goni et al., 2014) . It is unclear how PI(4,5)P2 binding to the KAKTLRK motif affects the FERM:FAT interaction. Further stimulated by the presence of other co-factors (such as cell surface receptor tails or local pH), this environment promotes loosening and/or disruption of the inhibitory FERM:kinase interaction, leading to Y397 phosphorylation within FAK clusters in trans. pY397-FAK recruits and activates Src kinases, stimulating phosphorylation of FAK and hence activation of kinase-dependent functions of the Src-FAK complex. Within this activated Src:FAK complex, FAK adopts a fully open conformation [ (Cai et al., 2008; Goni et al., 2014) and our unpublished data], maximally functioning as a scaffold for assembly, phosphorylation and co-localisation of ligands. It is unclear what triggers the conformational opening of FAT required for Y925 phosphorylation and Grb2 binding. It is possible that FAT opening is a probabilistic event, gaining biological significance in a clustered Src-FAK population (Kadare et al., 2015) . FAT opening and Grb2 binding disrupt the interaction with paxillin, whereas a fully deployed and disassembled FAK may be a better target for proteolytic cleavage and phosphatases. These and other events may trigger FA disassembly and turnover (discussed in greater detail in (Arold, 2011; Hall et al., 2011) ).
The available mechanistic data may also explain why FAK functions as a kinase-independent adaptor in early spreading adhesions. In these structures paxillin binds to another molecule, Nudel, and hence does not cluster and dimerise FAK (Shan et al., 2009) . The absence of FAK clusters and autophosphorylation may explain why FAK functions as a kinase-independent adaptor in early spreading adhesions, in conjunction with n-Wasp and Arp2/3 to control assembly and dynamics of the actin cytoskeleton (Serrels et al., 2007) .
FAK in the nucleus
Detachment of cells from the extracellular matrix can induce anoikis, mediated by the tumour suppressor p53. This detachmenttriggered apoptosis is subverted in cancer cells, allowing metastatic Phosphorylated residues are indicated by a P on a coloured circle, where red denotes Y397 and orange is used for other tyrosine residues. Serine phosphorylation events are not included. The FERM:FAT interaction in dimeric FAK is shown in trans (see Section 6), however mechanisms in which a FERM:FAT interaction in cis stabilises FAK dimers cannot be ruled out. At FAs, functionally important clustering of FAK molecules occurs. These clusters were not drawn for reasons of clarity. Trans-autophosphorylation of Y397 at FAs is shown to imply transient FERM:kinase dissociation across the W266-meditated dimer. Please note that autophosphorylation following PIP2-induced clustering was suggested to proceed without FERM:kinase dissociation (Goni et al., 2014) . Phosphorylation of Y925 and subsequent recruitment of Grb2 is incompatible with the interaction of FAT with paxillin. In mature FAs, other mechanisms can still attach FAK to focal adhesions, such as an interaction with talin, which does not need an assembled 4-helix bundle (Chen et al., 1995; Hayashi et al., 2002; Lawson et al., 2012) . However interaction with Grb2 correlates with mechanisms leading to FA dissociation (Ezratty et al., 2005) . Please refer to Sections 6 and 9.1e9.3. for a detailed description. 6   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66   67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130 tumour cells to invade other tissues. It was proposed that FAK inhibits p53 following cell detachment (Fu et al., 2012; Golubovskaya et al., 2008a; Lim et al., 2008) . If focal adhesion contacts are lost, FAK translocates into the nucleus, where it sequesters and inactivates p53 and other pro-apoptotic effectors in a kinaseindependent manner, thereby promoting cell survival. To achieve inactivation of p53, the FAK FERM domain functions as an adaptor between p53 and the ubiquitin E3 ligase murine double minute-2 (Mdm2), to promote p53 ubiquitination and degradation (Golubovskaya et al., 2005; Lim et al., 2008) . In the nucleus, FAK also influences DNA methylation through direct interaction with the methyl-CpG-binding domain protein 2 (MBD2) (Luo et al., 2009 ). MBD2 binds cytosine-methylated CpG islands, recruits histone deacetylases and DNA methyltransferases, and thus acts as a transcriptional repressor (Berger and Bird, 2005) . The interaction with FAK blocks MBD2 from recognising methylated CpG. It was shown that this association enhances FAK's nuclear localisation and allows it to regulate heterochromatin remodelling and myogenin expression during muscle differentiation (Luo et al., 2009 ). Thus, the controlled nuclear localisation allows FAK to logically link membrane-proximal stimuli with gene expression and hence to establish a link between adhesion, motility, survival and epigenetic changes (Cance and Golubovskaya, 2008; Fu et al., 2012) . Nuclear localization is promoted by an NLS that includes the K 216 AKTLRK basic cluster on the FERM domain and that is also required for the interaction between FERM and FAT. Through yeast two-hybrid screening and cell lysate pull-down assays, it was shown that MBD2 binds directly to the FAT domain of both FAK and Pyk2 (Luo et al., 2009 ). The MBD domain of MBD2 is sufficient for this interaction, but additional residues from the glycineearginine rich (GR) region increase the affinity. Based on the available structural framework of FAK, we speculate that upon binding to FAT, MBD2 disrupts the FAT:FERM interaction and reveals the NLS, promoting nuclear import (Brami-Cherrier et al., 2014) . In the absence of specific local enrichment, nuclear FAK is expected to remain monomeric, a hypothesis compatible with its function as a kinase-independent scaffold inhibiting pro-apoptotic factors such as p53.
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Pyk2 idiosyncrasies
In contrast to FAK, which is ubiquitous and highly expressed during embryogenesis, Pyk2 appears at later developmental stages and is abundant only in specific cell types, especially neurons (Menegon et al., 1999) . Nonetheless, Pyk2 is of high physiological and biomedical relevance. In cell types where both FAK and Pyk2 are present, Pyk2 can synergise with FAK, or compensate for a loss of FAK (resulting from knockout or specific inhibitors, for example), and thus promote cancer cell survival and metastasis (Sulzmaier et al., 2014; Weis et al., 2008) . Indeed, Pyk2 expression is increased in gliomas, hepatocellular carcinoma, lung, breast and prostate cancers, and has been proposed as a therapeutic target for invasive cancers (Allen et al., 2009; Lipinski and Loftus, 2010; Loftus et al., 2009; Stanzione et al., 2001; Sun et al., 2008 Sun et al., , 2011 . Deregulation of Pyk2 in cell types where it is abundant, such as neurons, osteoclasts and macrophages, has been linked to diseases associated with these cell types, such as neurodegeneration, osteoporosis and inflammation (Gil-Henn et al., 2007; Lambert et al., 2013; Okigaki et al., 2003) . Importantly, the Pyk2 gene (PTK2B) was recently discovered to be one of the genetic risk factors for Alzheimer's disease (Lambert et al., 2013) .
Conserved mechanism despite differences?
FAK and Pyk2 share the same domain organization Lev et al., 1995b) (Fig. 5) . Given the high sequence identity of the FERM, kinase and FAT domains of these two proteins, it is expected that fundamental mechanistic aspects of protein activation are conserved. Indeed, Pyk2 can transiently selfassociate through interactions involving both its N-terminal and C-terminal domains (Park et al., 2004) . Self-association is required for trans-autophosphorylation on Y402 (corresponding to FAK Y397) (Bartos et al., 2010; Park et al., 2004) . pY402 binds and activates Src family kinases, which then phosphorylate other residues in Pyk2 and associated proteins (Dikic et al., 1996; Park et al., 2004) . The Pyk2 FAT domain also binds to paxillin LD motifs (Lulo et al., 2009 ). However, unlike FAK, Pyk2 is not strongly localized to focal adhesions in most cell types. Moreover, Pyk2 has the unique capacity to sense calcium ions (Ca 2þ ). This capacity enables Pyk2 to act as a central transducer of the Ca 2þ signal in FA turnover (Hashido et al., 2006) and allows it to execute specific functions outside of FAs (Andreev et al., 1999) . For example, Pyk2 activation in neurons by Ca 2þ promotes neurite outgrowth and is involved in synaptic plasticity . Pyk2 has evolved through FAK gene duplication in vertebrates and subsequent specialisation (Corsi et al., 2006 /CaM); however the proposed mechanisms differ (Kohno et al., 2008; Xie et al., 2008) . Kohno et al. reported that Ca 2þ /CaM binds to, and dimerizes, the FERM domain, which is necessary for Pyk2 trans-autophosphorylation (Kohno et al., 2008 (Xie et al., 2008) . Both groups used sequence homology to known CaM binding motifs to identify, and mutationally disrupt, their putative CaM binding site. However, in both cases, the suggested binding site is mostly buried inside the FERM or kinase domain structure, inaccessible to canonical Ca 2þ /CaM interactions (Fig. 5B) .
More indirect and often cell-type specific mechanisms also exist. In neurons Ca 2þ /CaM has been reported to bind to the postsynaptic density protein 95 (PSD-95), releasing an autoinhibitory interaction and allowing PSD-95 to cluster and activate Pyk2 (Bartos et al., 2010) . The PSD-95 SH3 domain binds to a proline-rich region situated between the kinase and FAT domain of Pyk2 (Seabold et al., 2003) . PSD-95 forms oligomers, and Pyk2 dimerisation or clustering through Ca 2þ /CaMePSD-95 triggers Y402 autophosphorylation in trans. Increased Ca 2þ levels also trigger Pyk2 autophosphorylation through activation of protein kinase C (PKC) (Lev et al., 1995a) or calmodulin-dependent kinase II (CaMKII) (Ginnan and Singer, 2002; Guo et al., 2004; Zwick et al., 1999) . In PC12 cells, Ca 2þ entry triggers both Pyk2 activation and cytonuclear accumulation and the Ca 2þ -dependent Ser/Thr phosphatase calcineurin is required for these effects (Faure et al., 2007) . The role of protein kinase A (PKA) and protein phosphatase 1(PP1) has also been suggested {Park, 2000 #806; Battistone, 2014 #808; Rotfeld, 2014 #807}. Pyk2 contains several putative (de)phosphorylation sites for these kinases and phosphatases, mainly located in the kinase-FAT linker {Oppermann, 2009 #606}. Thus, Pyk2 appears to be able to detect multiple signals triggered by Ca 2þ . However, the molecular basis for how Pyk2 translates changes in cytoplasmic calcium levels into biological responses remains to be established. Interestingly, the crystal structure of the isolated Pyk2 FERM domain (PDB accession nr. 4EKU) shows identical FERM:FERM dimers as observed and as demonstrated to be biologically relevant to FAK (Brami-Cherrier et al., 2014) (Fig. 3B) . We speculate that Pyk2 has adapted the ligand-induced dimer-activation mechanism of FAK so that Ca 2þ -dependent mechanisms stabilise a weak FERM:-FERM interaction for productive trans-autophosphorylation . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 
Nuclear Pyk2
Like FAK, Pyk2 is able to translocate to the nucleus (Faure et al., 2007) . Pyk2 accumulates in the nucleus following Ca 2þ influx (Faure et al., 2007) , suggesting a correlation between Ca 2þ /CaMbinding and nuclear localisation. This translocation involves dephosphorylation of S778 by calcineurin, a Ca 2þ /calmodulin activated phosphatase, which appears to inactivate a nuclear export sequence (Faure et al., 2013) . Like FAK, Pyk2 associates with MBD2 (Luo et al., 2009) , and this association correlates with a nuclear localisation of both proteins. The physiological effects of the Pyk2:MBD2 association, especially in neurons and other cell types where Pyk2 plays a central role, remain unknown, although it has been suggested that the Pyk2:MBD2 complex might regulate gene expression (Mei and Xiong, 2010) . Formation of such a complex may reduce MBD2 binding to methylated DNA and indirectly enhance gene expression. The atomic basis for the interaction between Pyk2 and MBD2 is unknown. Available data strongly suggest that MBD2 associates in the same way with the FAT domains of either FAK or Pyk2 (Luo et al., 2009) . Indeed, the FAK and Pyk2 FAT domains share 57% sequence identity, form the same 3D structure and bind paxillin LD motifs in the same way (Fig. 5C) (Alam et al., 2014; Hoellerer et al., 2003; Lulo et al., 2009; Vanarotti et al., 2014) .
Targeted inhibition of FAK and Pyk2
Owing to their central role in linking adhesion, migration and survival, FAK and Pyk2 constitute potential therapeutic targets. Targeted small-molecule inhibitors for FAK produce encouraging results in mouse models, where they prevented growth, metastasis, vascular permeability and angiogenesis of tumours (reviewed in (Sulzmaier et al., 2014) ). Of particular interest, these inhibitors also sensitise cancer cells to chemotherapy, thus providing dual benefits. Currently most FAK inhibitors, and all those in clinical phase I/II trials, are ATP-competitive kinase inhibitors (Sulzmaier et al., 2014) . Some compounds achieve enhanced specificity by stabilising the particular helical conformation of the FAK kinase activation loop 'DFG' motif Roberts et al., 2008) . However developing highly specific ATP-competitive agents for FAK remains challenging, and proteineprotein interaction inhibitors (PPIIs) would provide an attractive novel tool for cancer therapy (Morelli et al., 2011) . Several PPIIs were reported for FAK that showed anti-tumour activity in xenograft mouse models, and sensitised cancer cells to chemotherapy (Golubovskaya et al., , 2013 (Golubovskaya et al., , 2008b Hochwald et al., 2009; Kurenova et al., 2014 Kurenova et al., , 2009 ). The proposed targets of those compounds are Y397, the reported p53 binding site on FERM, and the reported VEGFR-3 binding site on the FAT domain. These compounds, which were identified through in silico docking studies, are currently only weak inhibitors; they require high micromolar dosages and their selectivity and precise mode of action remain to be completely established.
Currently, the only Pyk2 inhibitors in preclinical trials are ATPcompetitive kinase inhibitors (Sulzmaier et al., 2014) . For function-specific anti-Pyk2 PPIIs, especially in diseases other than cancer, a better evaluation of the biological role of Pyk2 is required to assess the potential benefits or risks of inhibition. For example it is not known whether it is an increase or a decrease in Pyk2 function that contributes to an increased risk of Alzheimer's disease (Kaufman et al., 2015; Xu et al., 2014) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66   67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130 
Conclusions & remaining challenges
Despite recent advances in our mechanistic understanding of FAK and Pyk2, several aspects of their complex structure-function relationship remain elusive. For example, it is unclear how all those ligands that require the KAKTLRK basic motif on FERM synergise or compete for this motif. In fact, the possibility that mutations in the motif increase conformational dynamics of the F2 lobe, and thus allosterically block binding of ligands to different or remote sites on F2, cannot be excluded. Substantial F2 destabilisation is expected to disrupt the F2-mediated autoinhibition between the FERM and kinase domain. Hence, controlled F2 destabilisation might also explain how FAK activation results from c-Metepromoted phosphorylation of Y195 (Chen et al., 2011) , or PIAS-1emediated sumoylation of K152 (Kadare et al., 2003) , because both Y195 and K152 are buried inside the F2 fold.
It also remains to be determined how the 220 residueelong kinase-FAT linker blocks phosphorylation in cis of Y397, although this residue is located between the FERM and kinase domains. This linker region presents the lowest sequence similarity between FAK and Pyk2 (Fig. 5) , and it remains to be determined how these divergent sequences support the functional idiosyncrasies of both homologues.
Additional structural data would be required to better understand FAK's function in the nucleus, especially how FAK links p53 and Mdm2, and how FAK and Pyk2 interact with MBD2, resulting in changes in DNA methylation patterns. Further mechanistic insights, on an atomic level, would be needed to understand the role of these molecules in mechanotransduction (Bae et al., 2014; Berk et al., 1995) . Finally, understanding the function of FAK and Pyk2 also requires investigating the importance of noise, synergy and structural/functional heterogeneity within clustered FAK or Pyk2 populations embedded in adhesomes or other complex structures (Ladbury and Arold, 2012) . Understanding such complex systems on a molecular and holistic level might now be possible through hybrid methods combining experimental and computational methods with molecular imaging in cells or in cell-free systems (Kanchanawong et al., 2010; Wilhelm et al., 2014; Zaidel-Bar et al., 2007) . A detailed knowledge of the complex structure-function relationship of FAK and Pyk2 would enable precise targeting of proteineprotein interaction inhibitors, and might provide an inspiration for novel biotechnological applications and tools . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  591  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66 
